The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes

• Egile Nagusiak: Seo Ri Wui (Egilea), Ara Ko (Egilea), Ji In Ryu (Egilea), Eojin Sim (Egilea), Soo Jeong Lim (Egilea), Shin Ae Park (Egilea), Kwang Sung Kim (Egilea), Ha Kim (Egilea), Hyewon Youn (Egilea), Na Gyong Lee (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Adjuvant CIA09, composed of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-based cationic liposomes and the toll-like receptor 4 agonist de-<i>O</i>-acylated lipooligosaccharide (dLOS), has been shown to enhance antibody and cellular immune responses to varicella-zoster virus (VZV) gly...